MorphoSys AG (MOR)
MorphoSys Market Cap: 2.866B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 2.866B |
May 16, 2024 | 2.918B |
May 15, 2024 | 2.791B |
May 14, 2024 | 2.774B |
May 13, 2024 | 2.726B |
May 10, 2024 | 2.716B |
May 09, 2024 | 2.696B |
May 08, 2024 | 2.710B |
May 07, 2024 | 2.707B |
May 06, 2024 | 2.713B |
May 03, 2024 | 2.699B |
May 02, 2024 | 2.696B |
May 01, 2024 | 2.642B |
April 30, 2024 | 2.627B |
April 29, 2024 | 2.619B |
April 26, 2024 | 2.722B |
April 25, 2024 | 2.735B |
April 24, 2024 | 2.723B |
April 23, 2024 | 2.722B |
April 22, 2024 | 2.710B |
April 19, 2024 | 2.713B |
April 18, 2024 | 2.723B |
April 17, 2024 | 2.713B |
April 16, 2024 | 2.700B |
April 15, 2024 | 2.710B |
Date | Value |
---|---|
April 12, 2024 | 2.716B |
April 11, 2024 | 2.715B |
April 10, 2024 | 2.710B |
April 09, 2024 | 2.731B |
April 08, 2024 | 2.730B |
April 05, 2024 | 2.721B |
April 04, 2024 | 2.719B |
April 03, 2024 | 2.722B |
April 02, 2024 | 2.716B |
April 01, 2024 | 2.724B |
March 28, 2024 | 2.728B |
March 27, 2024 | 2.728B |
March 26, 2024 | 2.734B |
March 25, 2024 | 2.730B |
March 22, 2024 | 2.734B |
March 21, 2024 | 2.712B |
March 20, 2024 | 2.712B |
March 19, 2024 | 2.721B |
March 18, 2024 | 2.722B |
March 15, 2024 | 2.683B |
March 14, 2024 | 2.698B |
March 13, 2024 | 2.713B |
March 12, 2024 | 2.733B |
March 11, 2024 | 2.691B |
March 08, 2024 | 2.694B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Novartis AG | 209.28B |
Immatics NV | 1.129B |
Affimed NV | 79.94M |
InflaRx NV | 95.98M |
BioNTech SE | 21.84B |
Market Cap Related Metrics
PS Ratio | 10.11 |
PEG Ratio | -0.7222 |
Price to Book Value | 52.87 |
Price | 19.00 |
Earnings Yield | -7.91% |
PEGY Ratio | -0.7222 |